Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.53 |
| ▸ | FEN1 | P39748 | 1/20 | 0.53 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | JAK2 | O60674 | 1/20 | 0.49 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.49 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.49 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29009131 | 0.98 | TSHR (0.65) | TSHRALDH1A1ERCC5FEN1P2RX7 | |
| SCHEMBL28310911 | 0.92 | TSHR (0.59) | TSHRALDH1A1ERCC5FEN1P2RX7 | |
| SCHEMBL28218932 | 0.90 | TSHR (0.57) | TSHRALDH1A1ERCC5FEN1P2RX7 | |
| SCHEMBL5285030 | 0.87 | ALDH1A1 (0.52) | TSHRALDH1A1ERCC5FEN1P2RX7 | |
| Hydrochloric Acid SCHEMBL27715368 | 0.84 | TSHR (0.50) | TSHRALDH1A1ERCC5FEN1P2RX7 | |
| SCHEMBL7032023 | 0.83 | TSHR (0.71) | TSHRALDH1A1ERCC5FEN1P2RX7 | |
| SCHEMBL6143391 | 0.81 | CES2 (0.52) | TSHRALDH1A1P2RX7CES2CES1 | |
| SCHEMBL2831621 | 0.81 | TSHR (0.68) | TSHRALDH1A1ERCC5FEN1P2RX7 | |
| SCHEMBL29904615 | 0.81 | TSHR (1.00) | TSHRALDH1A1ERCC5FEN1P2RX7 | |
| SCHEMBL97298 | 0.81 | TSHR (1.00) | TSHRALDH1A1ERCC5FEN1P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1625 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304541-A1 | METHYLENE BLUE HAVING A REDUCED CONTENT OF N-NITROSO-AZURE B IMPURITY AND PROCESS FOR OBTAINING THE SAME | Icrom S.R.L. (IT) | 2025-10-02 | — | — | US | claimed |
| CN-116178139-A | Production method of 2, 3-dichlorobenzoyl chloride | 湖北丽康源化工有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-116037052-A | Continuous production equipment of 3.5 dichlorobenzoyl chloride | 山东兴元化工有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-115779825-A | Hydrolysis processing system for processing dichlorobenzoyl chloride and processing method thereof | 江苏万隆化学有限公司 | 2023-03-14 | — | — | CN | claimed |
| CN-216778835-U | High-efficient agitated vessel of two benzoyl chloride production | 山东嘉瑞化工有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-215428934-U | Catalytic cracking device is used in production of dichlorobenzoyl chloride | 酒泉亚佳化学有限公司 | 2022-01-07 | — | — | CN | claimed |
| CN-212396726-U | Reation kettle for preparation of dichlorobenzoyl chloride | 江苏万隆化学有限公司 | 2021-01-26 | — | — | CN | claimed |
| CN-212395909-U | Distillation still for preparing dichlorobenzoyl chloride | 江苏万隆化学有限公司 | 2021-01-26 | — | — | CN | claimed |
| CN-109098006-B | Cloth-sandwiched rubber material and preparation method thereof | 广州机械科学研究院有限公司 | 2021-01-26 | — | — | CN | claimed |
| CN-109678698-A | A kind of preparation method of 2,4 dichlorobenzyl chloride | 江苏佳麦化工有限公司 | 2019-04-26 | — | — | CN | claimed |
| WO-2000035888-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE | VYAS SHARAD KUMAR (IN) | 2000-06-22 | — | — | WO | claimed |
| EP-0963980-A2 | 1,2,4-Triazine derivative, its preparation and its use as reference marker for testing purity and stability of \"lamotrigine\ | THE WELLCOME FOUNDATION LIMITED (GB) | 1999-12-15 | — | — | EP | claimed |
| CN-1238454-A | Compound and use thereof | WELLCOME FOUND (GB) | 1999-12-15 | — | — | CN | claimed |
| US-5852047-A | Pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor | CAL INTERNATIONAL LIMITED (IE) | 1998-12-22 | — | — | US | claimed |
| EP-0741699-A1 | A PHARMACEUTICAL PRODUCT COMPRISING A SALICYLATE OF AN ESTERIFIABLE ACE-INHIBITOR | CAL INTERNATIONAL LIMITED (IE) | 1996-11-13 | — | — | EP | claimed |
| WO-1995020571-A1 | A PHARMACEUTICAL PRODUCT COMPRISING A SALICYLATE OF AN ESTERIFIABLE ACE-INHIBITOR | CAL INTERNATIONAL LIMITED (IE) | 1995-08-03 | — | — | WO | claimed |
| US-5334724-A | Preparation of substituted 2-chloropyridines | BAYER AKTIENGESELLSCHAFT (DE) | 1994-08-02 | — | — | US | claimed |
| EP-0438691-B1 | Process for the preparation of substituted 2-chloropyridines | BAYER AG (DE) | 1994-02-16 | — | — | EP | claimed |
| EP-0440329-A1 | S-substituted carbonyl substituted betathioacrylamide biocides and fungicides | ROHM AND HAAS COMPANY (US) | 1991-08-07 | — | — | EP | claimed |
| EP-0438691-A1 | Process for the preparation of substituted 2-chloropyridines | BAYER AG (DE) | 1991-07-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304541-A1 | METHYLENE BLUE HAVING A REDUCED CONTENT OF N-NITROSO-AZURE B IMPURITY AND PROCESS FOR OBTAINING THE SAME | MMAB, HBB, MB | TSHR 3182/4885ALDH1A1 702/4885ERCC5 292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.